Creative Planning’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Creative Planning’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3,000	Closed	-$14K	–	4225
2017 Q2	$14K	Sell	3,000 -4,000	-57%	-$17.9K	﹤0.01%	3434
2017 Q1	$35K	Buy	7,000 +1,000	+17%	+$9.62K	﹤0.01%	2735
2016 Q4	$67K	Buy	6,000 +3,000	+100%	+$28.2K	﹤0.01%	2157
2016 Q3	$28K	Buy	+3,000	New	+$25.1K	﹤0.01%	2810

Other funds holding FOMX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Creative Planning's FOMX Position: Q3 2017 in Review

Creative Planning sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q3 2017, closing a stake of 3,000 shares — an estimated $14K sold.

Creative Planning first reported a position in FOMX in Q3 2016 and held it in 4 quarters. The position peaked at $67K in Q4 2016. 45 funds tracked by Wall St. Rank hold FOMX as of Q3 2017.

Creative Planning reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q3 2017 after selling out during the quarter.
Creative Planning sold 3,000 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q3 2017, an estimated $14K.
Creative Planning first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q3 2016 and held it in 4 quarters.
Creative Planning's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $67K in Q4 2016.
45 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.